Alzheimer's disease

被引:485
作者
Blennow, Kaj [1 ]
de Leon, Mony J.
Zetterberg, Henrik
机构
[1] Sahlgrens Univ Hosp, Clin Neurochem Lab, Dept Neurosci & Physiol, SE-43180 Molndal, Sweden
[2] NYU, Sch Med, Ctr Brain Hlth, Dept Psychiat, New York, NY USA
[3] Nathan S Kline Inst Psychiat Res, New York, NY USA
关键词
D O I
10.1016/S0140-6736(06)69113-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Alzheimer's disease is the most common cause of dementia. Research advances have enabled detailed understanding of the molecular pathogenesis of the hallmarks of the disease-ie, plaques, composed of amyloid beta (A beta), and tangles, composed of hyperphosphorylated tau. However, as our knowledge increases so does our appreciation for the pathogenic complexity of the disorder. Familial Alzheimer's disease is a very rare autosomal dominant disease with early onset, Caused by mutations in the amyloid precursor protein and presenilin genes, both linked to A beta metabolism. By contrast with familial disease, sporadic Alzheimer's disease is very common with more than 15 million people affected worldwide. The cause of the sporadic form of the disease is unknown, probably because the disease is heterogeneous, caused by ageing in concert with a complex interaction of both genetic and environmental risk factors. This seminar reviews the key aspects of the disease, including epidemiology, genetics, pathogenesis, diagnosis, and treatment, as well as recent developments and controversies.
引用
收藏
页码:387 / 403
页数:17
相关论文
共 184 条
[71]   The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer's disease [J].
Höglund, K ;
Thelen, KM ;
Syversen, S ;
Sjögren, M ;
von Bergmann, K ;
Wallin, A ;
Vanmechelen, E ;
Vanderstichele, H ;
Lütjohann, D ;
Blennow, K .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2005, 19 (5-6) :256-265
[72]   Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease [J].
Holtzman, DM ;
Bales, KR ;
Tenkova, T ;
Fagan, AM ;
Parsadanian, M ;
Sartorius, LJ ;
Mackey, B ;
Olney, J ;
McKeel, D ;
Wozniak, D ;
Paul, SM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) :2892-2897
[73]   Modulation of secreted β-amyloid precursor protein and amyloid β peptide in brain by cholesterol [J].
Howland, DS ;
Trusko, SP ;
Savage, MJ ;
Reaume, AG ;
Lang, DM ;
Hirsch, JD ;
Maeda, N ;
Siman, R ;
Greenberg, BD ;
Scott, RM ;
Flood, DG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (26) :16576-16582
[74]   The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease [J].
Hutter-Paier, B ;
Huttunen, HJ ;
Puglielli, L ;
Eckman, CB ;
Kim, DY ;
Hofmeister, A ;
Moir, RD ;
Domnitz, SB ;
Frosch, MP ;
Windisch, M ;
Kovacs, DM .
NEURON, 2004, 44 (02) :227-238
[75]   Neurovascular regulation in the normal brain and in Alzheimer's disease [J].
Iadecola, C .
NATURE REVIEWS NEUROSCIENCE, 2004, 5 (05) :347-360
[76]   AXONAL DEGENERATION PROMOTES ABNORMAL ACCUMULATION OF AMYLOID BETA-PROTEIN IN ASCENDING GRACILE TRACT OF GRACILE AXONAL DYSTROPHY (GAD) MOUSE [J].
ICHIHARA, N ;
WU, J ;
CHUI, DH ;
YAMAZAKI, K ;
WAKABAYASHI, T ;
KIKUCHI, T .
BRAIN RESEARCH, 1995, 695 (02) :173-178
[77]   Tau pathology in Alzheimer disease and other tauopathies [J].
Iqbal, K ;
Alonso, ADC ;
Chen, S ;
Chohan, MO ;
El-Akkad, E ;
Gong, CX ;
Khatoon, S ;
Li, B ;
Liu, F ;
Rahman, A ;
Tanimukai, H ;
Grundke-Iqbal, I .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2005, 1739 (2-3) :198-210
[78]   Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI [J].
Jack, CR ;
Shiung, MM ;
Weigand, SD ;
O'Brien, PC ;
Gunter, JL ;
Boeve, BF ;
Knopman, DS ;
Smith, GE ;
Ivnik, RJ ;
Tangalos, EG ;
Petersen, RC .
NEUROLOGY, 2005, 65 (08) :1227-1231
[79]  
Jagust William, 2006, Alzheimers Dement, V2, P36, DOI 10.1016/j.jalz.2005.11.002
[80]   Microglial activation and β-amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice [J].
Jantzen, PT ;
Connor, KE ;
DiCarlo, G ;
Wenk, GL ;
Wallace, JL ;
Rojiani, AM ;
Coppola, D ;
Morgan, D ;
Gordon, MN .
JOURNAL OF NEUROSCIENCE, 2002, 22 (06) :2246-2254